Skip to content
Clinical Trials – home
GermanyBack to Germany

Clinical trials in Wangen im Allgäu

5 clinical trials in Wangen im Allgäu, Germany. Every trial is listed in the EU Clinical Trials Register and updated daily.

GermanyOur site in GermanyKlinischeStudien.de(opens in a new tab)
Wangen im Allgäu at a glance
5
clinical trials
  • Not yet recruiting0
  • Paediatric trials0
  • Research sites0
Type of trial
Recruitment status
Quick filters

5 trials in Wangen im Allgäu

Open in trial search
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Bi 690517
  • Sponsor:Boehringer Ingelheim Espana S.A.
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Azd5004
  • Sponsor:AstraZeneca AB
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:LY3841136 SODIUM
  • Sponsor:Eli Lilly & Co.
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Bevacizumab
  • Sponsor:Charite Universitaetsmedizin Berlin KöR
Registered drug
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Azd5004
  • Sponsor:AstraZeneca AB

Other cities in Germany

The busiest research cities in the country

All 515 cities in Germany

Clinical research in Wangen im Allgäu

What the registry says about research in the country

01 Wangen im Allgäu
Oncology
Clinical trial activity in Wangen im Allgäu includes research in neoplasms, with a focus on metastatic colorectal cancer. The studies are centered on comparing treatment approaches to find better options for people whose cancer has spread. Metastatic colorectal cancer Neoplasms Comparing treatment effectiveness This area reflects ongoing efforts to improve outcomes by testing new combinations and identifying more effective cancer care strategies.
Cardiovascular Disease
Research in cardiovascular diseases is examining people with type 2 diabetes, hypertension, and established cardiovascular disease. The main goal is to better prevent serious heart-related events and evaluate whether new treatment combinations can offer stronger protection. Cardiovascular disease Hypertension Type 2 diabetes mellitus Reducing heart failure and death risk These trials focus on improving treatment effectiveness for patients with overlapping metabolic and heart conditions.
Nutritional and Metabolic Diseases
Clinical trials in the nutritional and metabolic diseases area are studying obesity, overweight, and type 2 diabetes mellitus. The research is aimed at assessing whether new therapies can improve blood sugar control and support meaningful weight reduction. Obesity Overweight Type 2 diabetes mellitus Improving glycemic control and body weight These studies are especially relevant for people managing long-term metabolic health concerns.
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.